Selecting Antibacterial Agents for the Control of Surgical Infection: Mini-Review

References

• Periti P, Mazzei T. Principles of antimicrobial chemopro-phylaxis in surgery. Chemioterapia 1987; VI (3): 196-201.
   Google Scholar
• Caputo GM, Singer M, White S, et al. Infections due to antibiotic-resistant Gram-positive cocci. J Intern Med 1993; 8: 626–634.
   Web of Science ®Google Scholar
• Neu HC. Emerging trends in antimicrobial resistance in surgical infections. A review. Eur J Surg 1994; Suppl 573: 7-18.
   Google Scholar
• Thornsberry C. Epidemiology of staphylococcal infec-tions. A USA perspective. J Chemother 1994; 6 (Suppl 2): 61–65.
   PubMedGoogle Scholar
• Voss A, Milatovic D, Wallrauch-Schwarz C, et al. Methicillin-resistant Staphylococcus aureus in Europe. Eur J Clin Microbiol Infect Dis 1994; 13: 50–55.
   PubMed Web of Science ®Google Scholar
• Cruse PJE, Foord R. A five-year prospective study of 23,649 wounds. Arch Surg 1973; 107: 206–210.
   PubMed Web of Science ®Google Scholar
• Page CP, Bohnen JM, Fletcher R, et al. Antimicrobial prophylaxis for surgical wounds. Guidelines for clinical care. Arch Surg 1993; 128: 79–88.
   Google Scholar
• Culver DH, Horav TC, Gaynes RP, et al. National noso-comial infections surveillance system: surgical wound infection rates by wound class operative procedure, and patient risk index. Am J Med 1991; 91 (Suppl 3B): 152-157.
   Google Scholar
• Garibaldi RA, Cushing D, Lerer T. Risk factors for post-operative infection. Am J Med 1991; 91 (Suppl 3B): 158-163.
   Google Scholar
• Sherentz RJ, Morosok RD, Garibaldi RA, et al. Consensus paper on the surveillance of surgical wound infec-tions. The Society of Hospital Epidemiology of America, the Association for Practitioners in Infection Control, the Centers for Disease Control, the Surgical Infection Society. Infect Control Hosp Epidemiol 1992; 13: 599–605.
   Google Scholar
• American Medical Association. Drug Evaluations Annual 1994. Antimicrobial chemoprophylaxis for surgical patients 1994; 32: 1317-1321.
   Google Scholar
• American Society of Hospital Pharmacists Commission on Therapeutics. ASHP therapeutic guidelines on antimicro-bial prophylaxis in surgery. Clin Pharmacokinet 1992; 11: 483–513.
   Google Scholar
• Anonymous. Antimicrobial prophylaxis in surgery. Med Lett Drugs Ther 1995; 37: 79–82.
   Google Scholar
• Burnakis TG. Surgical antimicrobial prophylaxis: princi-ples and guidelines. Pharmacotherapy 1984; 4: 248–271.
   PubMed Web of Science ®Google Scholar
• Gorbach SL, Condon RE, Conte Jr-JE, et al. Evaluation of new anti-infective drugs for surgical prophylaxis. Clin Infect Dis 1992; 15 (Suppl 1): S313–S338.
   PubMedGoogle Scholar
• Hopkins CC. Antibiotic prophylaxis in clean surgery: peripheral vascular surgery, noncardiovascular thoracic surgery, herniorrhaphy, and mastectomy. Rev Infect Dis 1991; 13 (Suppl 10): S869–S873.
   PubMedGoogle Scholar
• Kernodle DS, Kaise AB. Postoperative infections and antimicrobial prophylaxis. In: Principles and Practice of Infectious Diseases, Mandell GL, Bennett JD, Dolin R, Eds, 4th ed. New York: Churchill Livingstone, 1995: 2742-2756.
   Google Scholar
• Nichols RC. Antibiotic prophylaxis in surgery. Curr Opin Infect Dis 1994; 7: 647–652.
   Web of Science ®Google Scholar
• Strachan CJL. Antibiotic prophylaxis in ‘clean’ surgical procedures. World J Surg 1982; 6: 273–280.
   PubMed Web of Science ®Google Scholar
• Strachan CJL. Antibiotic prophylaxis in peripheral vas-cular and orthopaedic prosthetic surgery. J Antimicrob Chemother 1993; 31 ( Suppl B): 65-78.
   Google Scholar
• Dickinson GM, Bisno AL. Antimicrobial prophylaxis of infection. Infect Dis Clin North Am 1995; 9: 783–804.
   PubMed Web of Science ®Google Scholar
• Haas DW, Kaiser AB. Antimicrobial prophylaxis of infections associated with foreign bodies. In: Infections Associated with Indwelling Medical Devices, Bisno AL, Waldvogel FA, Eds. Washington DC: American Society for Microbiology Press, 1994: 375.
   Google Scholar
• Mini E, Nobili S, Periti P. Methicillin-resistant staphylo-cocci in clean surgery. Is there a role for prophylaxis? Drugs 1998, Suppl in press.
   Google Scholar
• Classen DC, Evans RS, Pestotnik SL, et al. The timing of prophylactic administration of antibiotics and the risk of surgical wound infection. N Engl J Med 1992; 326: 281–286.
   PubMed Web of Science ®Google Scholar
• Sanderson PJ. Antimicrobial prophylaxis in surgery: microbiological factors. J Antimicrob Chemother 1993; 31 ( Suppl B): 1-9.
   Google Scholar
• Bisno AL, Waldvogel FA, (Eds). Infections Associated with Indwelling Medical Devices. American Society for Microbiology, Washington DC 1989.
   Google Scholar
• Sugarman B, Young EJ, (Eds). Infections Associated with Prosthetic Devices. CRC Press, Boca Raton, Florida 1984.
   Google Scholar
• Eng RHK, Hsieh A, Smith SM. Antibiotic killing of bac-teria: comparison of bacteria on surfaces and in liquid, grow-ing and nongrowing. Chemotherapy 1995; 41: 113–120.
   PubMed Web of Science ®Google Scholar
• Christensen CD, Simpson WA, Bison AL, et al. Adherence of slime producing strains of Staphylococcus epi-dermidis to smooth surfaces. Infect Immun 1982; 37: 318–326.
   PubMed Web of Science ®Google Scholar
• Peters G, Locci R, Pulvever G. Adherence and growth of coagulase-negative staphylococci on surfaces of intravenous catheters. J Infect Dis 1982; 146: 479–482.
   PubMed Web of Science ®Google Scholar
• Periti P. Preclinical and clinical evaluation of once-daily aminoglycoside chemotherapy. J Chemother 1995; 7 (4): 311–337.
   PubMed Web of Science ®Google Scholar
• Dougherty SH. Implant infections. In: Hand Book of Biomaterials Evaluation, VonRecum F, Ed. New York: MacMillan, 1986: 276-287.
   Google Scholar
• Cartel LL, Dutton RW. Type 1 and Type 2: a funda-mental dichotomy for all T-cell subsets. Curr Opin Immunol 1996; 8: 336–342.
   PubMed Web of Science ®Google Scholar
• Casadevall A. Crisis in infectious diseases: time for a new paradigm? Clin Infect Dis 1996; 23: 790–794.
   PubMed Web of Science ®Google Scholar
• Tracey Kj, Cerami A. Tumor necrosis factor: a pleiotropic cytokine and therapeutic target. Annu Rev Med 1994; 45: 491–503.
   PubMed Web of Science ®Google Scholar
• Suter PM, Suter S, Giradin E, Roux-Lombard P, Grau GE, Dayer JM. High bronchoalveolar levels of tumor necrosis factor and its inhibitor, interleukin-1, interferon and elastase in patients with adult respiratory distress syndrome after trauma, shock or sepsis. Am Rev Respir Dis 1992; 145: 1016-1022.
   Google Scholar
• Zabel P, Schade FU. Pentoxifylline and tumour necrosis factor-induced lung injury. Eur Respir J 1994; 7: 1389–1391.
   PubMed Web of Science ®Google Scholar
• Mohler J, Fantin B, Mainardi JL, Carbon C. Influence of antimicrobial therapy on kinetics of tumor necrosis factor levels in experimental endocarditis caused by Klebsiella pneu-moniae. Antimicrob Agents Chemother 1994; 38: 1017–1022.
   PubMed Web of Science ®Google Scholar
• Horn DL, Opal SM, Lomastro E. Antibiotics, cytokines, and endotoxin: a complex and evolving relationship in Gram-negative sepsis. Scand J Infect Dis 1996; Suppl 10: 9-13.
   Google Scholar
• Kusser WC, Ishiguro EE. Effects of aminoglycosides and spectinomycin on the synthesis and release of lipopolysaccha-ride by Escherichia coli. Antimicrob Agents Chemother 1988; 32: 1247–1250.
   PubMed Web of Science ®Google Scholar
• Foca A, Matera G, Iannello D, Berlinghieri MC, Liberto MC. Aminoglycosides modify the in vitro metachromatic reac-tion and murine generalized Shwartzman phenomenon induced by Salmonella minnesota R595 lipopolysaccharide. Antimicrob Agents Chemother 1991; 35 (10): 2161–2164.
   PubMed Web of Science ®Google Scholar
• Foca A, Matera G, Berlinghieri MC, Liberto MC, De Sarro GB. Teicoplanin reduces in-vitro reactivity and murine lethality of Salmonella minnesota R595 lipopolysaccharide. J Antimicrob Chemother 1992; 29: 443–446.
   PubMed Web of Science ®Google Scholar
• Foca A, Matera G, Berlinghieri MC. Inhibition of endo-toxin-induced interleukin 8 release by teicoplanin in human whole blood. Eur J Clin Microbiol Infect Dis 1993; 12: 940–944.
   PubMed Web of Science ®Google Scholar
• Kirikae T, Nakano M, Morrison DC. Antibiotic-induced endotoxin release from bacteria and its clinical significance - Review. Microbiol Immunol 1997; 41 (4): 285–294.
   PubMed Web of Science ®Google Scholar
• Kadurugamuwa JL, Beveridge TJ. Natural release of vir-ulence factors in membrane vesicles by Pseudomonas aerugi-nosa and the effect of aminoglycoside antibiotics on their release. J Antimicrob Chemother 1997; 40: 615–621.
   PubMed Web of Science ®Google Scholar
• Siedlar M, Szczepanik A, Wieckiewicz J, Pituch-Noworolska A, Zembala M. Vancomycin down-regulates lipopolysaccharide-induced tumour necrosis factor alpha (TNFa) production and TNFa-mRNA accumulation in human blood monocytes. Immunopharmacology 1997; 35: 265–271.
   PubMed Web of Science ®Google Scholar
• Labro MT. The prohost effect of antimicrobial agents as a predictor of clinical outcome. J Chemother 1997; 9 (Suppl 1): 100–108.
   PubMedGoogle Scholar
• Periti P. Immunofarmacologia di betalattamine parenter-ali. Farm Ter 1997; XIV (3/4): 56-67.
   Google Scholar
• Mattsson E, Verhage L, Rollof J, Fleer A, Verhoek J, Van Dijk H. Peptidoglycan and teichoic acid from Staphylococcus epidermidis stimulate human monocytes to release tumour necrosis factor-alpha, interleukin-1 beta and interleukin-6. FEMS Immunol Med Microbiol 1993; 7: 281–287.
   PubMedGoogle Scholar
• Heumann D, Barras C, Severin A, Glauser MP, Tomasz A. Gram-positive cell walls stimulate synthesis of rumor necro-sis factor alpha and interleukin-6 by human monocytes. Infect Immun 1994; 62: 2715-2721.
   Google Scholar
• Debets JMH, Kampmeijer R, Van der Linden MPH, Burman WA, Van der Linden CJ. Plasma tumor necrosis fac-tor and mortality in critically ill septic patients. Crit Care Med 1989; 17: 489–493.
   PubMed Web of Science ®Google Scholar
• Malhotra R, Bird MI. L-selection: a novel receptor for lipopolysaccharide and its potential role in bacterial sepsis. BioEssays 1997; 19 (10): 919–923.
   PubMed Web of Science ®Google Scholar
• Hurley JC. Antibiotic-induced release of endotoxin: a reappraisal. Clin Infect Dis 1992; 15: 840–854.
   PubMed Web of Science ®Google Scholar
• Horn DL, Opal SM, Lonastro E. Antibiotics, cytokines, and endotoxin: a complex and evolving relationship in Gram-negative sepsis. Scand J Infect Dis 1996; Suppl 101: 9-13.
   Google Scholar
• Jackson JJ, Kropp H. Betea-lactam antibiotic-induced release of free endotoxin: in vitro comparison of penicillin-binding protein (PBP)-2-specific imipenem and PBP-3-specific ceftazidime. J Infect Dis 1992; 165: 1033-1041.
   Google Scholar
• Prins JM, van Agtmael MA, Kuijper EJ, van Deventer SJH, Speelman P. Antibiotic-induced endotoxin release in patients with Gram-negative urosepsis: a double-blind study comparing imipenem and ceftazidime. J Infect Dis 1995; 172: 886–891.
   PubMed Web of Science ®Google Scholar
• Eng RHK, Smith SM, Fan-Havard P, Ogbara T. Effect of antibiotics on endotoxin release from Gram-negative bacte-ria. Diag Microbiol Infect Dis 1993; 16: 185–189.
   PubMed Web of Science ®Google Scholar
• Gardlund B, Sjolin J, Nilsson A, Roll M, Wickerts CJ, Wretlind B. Plasma levels of cytokines in primary septic shock in humans: correlation with disease severity. J Infect Dis 1995; 172: 296–301.
   PubMed Web of Science ®Google Scholar
• Hack CE, Hart M, Strack van Schijndel RJM, et al. Interleukin-8 in sepsis: relation to shock and inflammatory mediators. Infect Immun 1992; 60: 2835-2842.
   Google Scholar
• Beutler B, Cerami A. Tumor necrosis, cachexia, shock, and inflammation: a common mediator. Annu Rev Biochem 1988; 57: 505–518.
   PubMed Web of Science ®Google Scholar
• Lynn WA. Anti-endotoxin therapeutic options for the treatment of sepsis. J Antimicrob Chemother 1998; 41 ( Suppl A): 71-80.
   Google Scholar
• Gupta D, Jin Y-P, Dziarski R. Peptidoglycan induces transcription and secretion of TNFa and activation of lyn, extracellular signal-regulated kinase, and rsk signal transduc-tion proteins in mouse macrophages. J Immunol 1995; 155: 2620–2630.
   PubMed Web of Science ®Google Scholar
• Kragsbjerg P, Holmberg H, Vikerf ors T. Dynamics of blood cytokine concentrations in patients with bacteremic infections. Scand J Infect Dis 1996; 28: 391–398.
   Google Scholar
• Endo S, Inada K, Kikuchi M, et al. Clinical effects of intramuscular administration of a small dose of polymyxin B to patients with endotoxemia. Res Comm Chem Pathol Pharm 1994; 83 (2): 223–235.
   PubMedGoogle Scholar
• Periti P. Introduction: cephalosporin generations. J Chemother 1996; 8 (Suppl 2): 3–6.
   Google Scholar